Boston Cancer Group — Memphis, Tennessee

Boston Cancer Group is a clinical research site located in Memphis, Tennessee, United States 38119.

Crixeo Health Trust Score: 63/100 (FAIR). This profile has not yet been claimed by the site owner.

Boston Cancer Group has participated in 3 clinical trials.

Therapeutic areas: Head and Neck Cancer, Leukemia, Lung Cancer.

Sponsors: Matrix Pharmaceutical, Maxim Pharmaceuticals, Spectrum Pharmaceuticals, Inc.

Sponsor Feasibility Report

Trust Score: 63/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Boston Cancer Group?

Boston Cancer Group has a Crixeo Trust Score of 63/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Boston Cancer Group conducted?

Boston Cancer Group has 3 clinical trials on record. Their work covers Head and Neck Cancer, Leukemia, Lung Cancer.

Is Boston Cancer Group accredited by Crixeo Health?

Boston Cancer Group has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Boston Cancer Group?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.